|
C16ORF70 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.3981999999998E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.019960E-04 |
| Normal-vs-Stage2 |
4.372800E-01 |
| Normal-vs-Stage3 |
3.56000000000245E-05 |
| Normal-vs-Stage4 |
4.78210000043333E-07 |
| Stage1-vs-Stage2 |
1.047730E-02 |
| Stage1-vs-Stage3 |
1.134440E-01 |
| Stage1-vs-Stage4 |
8.396200E-03 |
| Stage2-vs-Stage3 |
2.802100E-03 |
| Stage2-vs-Stage4 |
3.405600E-04 |
| Stage3-vs-Stage4 |
3.007800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.90509999999211E-05 |
| Normal-vs-AfricanAmerican |
3.058500E-03 |
| Normal-vs-Asian |
2.721500E-03 |
| Caucasian-vs-AfricanAmerican |
8.969200E-01 |
| Caucasian-vs-Asian |
6.689200E-01 |
| AfricanAmerican-vs-Asian |
6.557400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.73359999999479E-05 |
| Normal-vs-Female |
1.009290E-04 |
| Male-vs-Female |
6.456400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.63529999999935E-05 |
| Normal-vs-Age(41-60Yrs) |
1.167910E-04 |
| Normal-vs-Age(61-80Yrs) |
2.635300E-03 |
| Normal-vs-Age(81-100Yrs) |
3.998200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.143800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.396000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.690800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.819600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.559600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.551400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.801200E-03 |
| Classical-VS-Follicular |
2.218400E-01 |
| Classical-VS-Other |
6.313000E-01 |
| Classical-VS-Normal |
1.035090E-04 |
| Tall-VS-Follicular |
7.590800E-04 |
| Tall-VS-Other |
3.640400E-01 |
| Tall-VS-Normal |
2.96109999964322E-07 |
| Follicular-VS-Other |
4.391400E-01 |
| Follicular-VS-Normal |
2.493800E-02 |
| Other-VS-Normal |
4.274100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.057000E-03 |
| Normal-vs-N1 |
2.01590000026286E-07 |
| N0-vs-N1 |
6.719300E-03 |
|
|
